These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

937 related items for PubMed ID: 24602805

  • 1. The impact of the prevention strategies on the indirect effects of CMV infection in solid organ transplant recipients.
    Roman A, Manito N, Campistol JM, Cuervas-Mons V, Almenar L, Arias M, Casafont F, del Castillo D, Crespo-Leiro MG, Delgado JF, Herrero JI, Jara P, Morales JM, Navarro M, Oppenheimer F, Prieto M, Pulpón LA, Rimola A, Serón D, Ussetti P, ATOS working group.
    Transplant Rev (Orlando); 2014 Apr; 28(2):84-91. PubMed ID: 24602805
    [Abstract] [Full Text] [Related]

  • 2. Viral load, CMV-specific T-cell immune response and cytomegalovirus disease in solid organ transplant recipients at higher risk for cytomegalovirus infection during preemptive therapy.
    Martín-Gandul C, Pérez-Romero P, Blanco-Lobo P, Benmarzouk-Hidalgo OJ, Sánchez M, Gentil MA, Bernal C, Sobrino JM, Rodríguez-Hernández MJ, Cordero E, Spanish Network for Research in Infectious Diseases (REIPI).
    Transpl Int; 2014 Oct; 27(10):1060-8. PubMed ID: 24964364
    [Abstract] [Full Text] [Related]

  • 3. [Cytomegalovirus infection after solid-organ transplantation, its risk factors, direct and indirect effects and prevention strategies].
    Varga M, Remport A, Czebe K, Péter A, Toronyi E, Sárváry E, Fehérvári I, Sulyok B, Járay J.
    Orv Hetil; 2008 Mar 23; 149(12):551-8. PubMed ID: 18343771
    [Abstract] [Full Text] [Related]

  • 4. Immunomodulation by hyperimmunoglobulins after solid organ transplantation: Beyond prevention of viral infection.
    van Gent R, Metselaar HJ, Kwekkeboom J.
    Transplant Rev (Orlando); 2017 Apr 23; 31(2):78-86. PubMed ID: 28131494
    [Abstract] [Full Text] [Related]

  • 5. Allograft rejection predicts the occurrence of late-onset cytomegalovirus (CMV) disease among CMV-mismatched solid organ transplant patients receiving prophylaxis with oral ganciclovir.
    Razonable RR, Rivero A, Rodriguez A, Wilson J, Daniels J, Jenkins G, Larson T, Hellinger WC, Spivey JR, Paya CV.
    J Infect Dis; 2001 Dec 01; 184(11):1461-4. PubMed ID: 11709790
    [Abstract] [Full Text] [Related]

  • 6. Cytomegalovirus infection post-pancreas-kidney transplantation--results of antiviral prophylaxis in high-risk patients.
    Fallatah SM, Marquez MA, Bazerbachi F, Schiff JR, Cattral MS, McGilvray ID, Norgate A, Selzner M, Rotstein C, Husain S.
    Clin Transplant; 2013 Dec 01; 27(4):503-9. PubMed ID: 23731387
    [Abstract] [Full Text] [Related]

  • 7. Benefits of cytomegalovirus prophylaxis in solid organ transplantation.
    Pescovitz MD.
    Transplantation; 2006 Jul 27; 82(2 Suppl):S4-8. PubMed ID: 16858270
    [Abstract] [Full Text] [Related]

  • 8. Improving outcomes for solid-organ transplant recipients at risk from cytomegalovirus infection: late-onset disease and indirect consequences.
    Legendre C, Pascual M.
    Clin Infect Dis; 2008 Mar 01; 46(5):732-40. PubMed ID: 18220478
    [Abstract] [Full Text] [Related]

  • 9. Revisiting the effects of CMV on long-term transplant outcome.
    Baron C, Forconi C, Lebranchu Y.
    Curr Opin Organ Transplant; 2010 Aug 01; 15(4):492-8. PubMed ID: 20631617
    [Abstract] [Full Text] [Related]

  • 10. High risk of cytomegalovirus infection following solid organ transplantation despite prophylactic therapy.
    Harvala H, Stewart C, Muller K, Burns S, Marson L, MacGilchrist A, Johannessen I.
    J Med Virol; 2013 May 01; 85(5):893-8. PubMed ID: 23508914
    [Abstract] [Full Text] [Related]

  • 11. [The significance of risk-adapted antiviral prophylaxis and modern virus diagnosis for organ survival after kidney transplantation].
    Fricke L, Steinhoff J, Hartwig-Weber I, Bein G.
    Dtsch Med Wochenschr; 1997 May 02; 122(18):565-71. PubMed ID: 9190308
    [Abstract] [Full Text] [Related]

  • 12. Cytomegalovirus infection in solid organ transplant recipients: new challenges and their implications for preventive strategies.
    Singh N.
    J Clin Virol; 2006 Apr 02; 35(4):474-7. PubMed ID: 16406798
    [Abstract] [Full Text] [Related]

  • 13. CMV-hyperimmune globulin for preventing cytomegalovirus infection and disease in solid organ transplant recipients: a meta-analysis.
    Bonaros N, Mayer B, Schachner T, Laufer G, Kocher A.
    Clin Transplant; 2008 Apr 02; 22(1):89-97. PubMed ID: 18217909
    [Abstract] [Full Text] [Related]

  • 14. [Cytomegalovirus infection in transplant recipients].
    Gondo H.
    Nihon Rinsho; 1998 Jan 02; 56(1):173-8. PubMed ID: 9465685
    [Abstract] [Full Text] [Related]

  • 15. Cytomegalovirus infection and disease in the new era of immunosuppression following solid organ transplantation.
    Fisher RA.
    Transpl Infect Dis; 2009 Jun 02; 11(3):195-202. PubMed ID: 19228345
    [Abstract] [Full Text] [Related]

  • 16. Influence of cytomegalovirus disease in outcome of solid organ transplant patients.
    Linares L, Sanclemente G, Cervera C, Hoyo I, Cofán F, Ricart MJ, Pérez-Villa F, Navasa M, Marcos MA, Antón A, Pumarola T, Moreno A.
    Transplant Proc; 2011 Jun 02; 43(6):2145-8. PubMed ID: 21839217
    [Abstract] [Full Text] [Related]

  • 17. Reduced risk of cytomegalovirus infection in solid organ transplant recipients treated with sirolimus: a pooled analysis of clinical trials.
    Demopoulos L, Polinsky M, Steele G, Mines D, Blum M, Caulfield M, Adamkovic A, Liu Q, Harler MB, Hahn C, Singh A.
    Transplant Proc; 2008 Jun 02; 40(5):1407-10. PubMed ID: 18589118
    [Abstract] [Full Text] [Related]

  • 18. Cytomegalovirus: occurrence, severity, and effect on graft survival in simultaneous pancreas-kidney transplantation.
    Ricart MJ, Malaise J, Moreno A, Crespo M, Fernández-Cruz L, Euro-SPK Study Group.
    Nephrol Dial Transplant; 2005 May 02; 20 Suppl 2():ii25-ii32, ii62. PubMed ID: 15814546
    [Abstract] [Full Text] [Related]

  • 19. Effect of cytomegalovirus prophylaxis with immunoglobulin or with antiviral drugs on post-transplant non-Hodgkin lymphoma: a multicentre retrospective analysis.
    Opelz G, Daniel V, Naujokat C, Fickenscher H, Döhler B.
    Lancet Oncol; 2007 Mar 02; 8(3):212-8. PubMed ID: 17329191
    [Abstract] [Full Text] [Related]

  • 20. Cytomegalovirus infection in living donor liver transplant recipients significantly impacts the early post-transplant outcome: A single center experience.
    Yadav SK, Saigal S, Choudhary NS, Saha S, Sah JK, Saraf N, Kumar N, Goja S, Rastogi A, Bhangui P, Soin AS.
    Transpl Infect Dis; 2018 Aug 02; 20(4):e12905. PubMed ID: 29668120
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.